Company intelligence / Profile preview
Xynomic Pharmaceuticals
Poway, California, United Statesxynomicpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Xynomic is a clinical-stage biopharmaceutical company developing innovative small molecule therapies for oncology. Its lead asset abexinostat has completed dosing in a China phase 2 trial as third-line therapy for relapsed/refractory follicular lymphoma with excellent preliminary results. The company is preparing an NDA filing to the China NMPA. Abexinostat also received two FDA fast-track designations. Other assets include XP‑105 (mTORC1/2 inhibitor) ready for phase 2 trials and XP‑102/BI‑882370 (pan‑RAF inhibitor) at the preclinical or IND stage.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesPotentially monoclonal antibodies in preclinical work
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
WuXi STA/WuXi AppTec – preferred CDMO partner providing integrated CMC services from API to drug product manufacturing support.
Beyond the preview
Go deeper on Xynomic Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xynomic Pharmaceuticals.